FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Deuser Susan M
2. Issuer Name and Ticker or Trading Symbol

ALLIED HEALTHCARE PRODUCTS INC [ AHPI ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

1720 SUBLETTE AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)

11/12/2020
(Street)

ST. LOUIS, MO 63110
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock $1.22           12/31/2021 (1)12/31/2029 (2)Common Stock 5000  5000 D  
Option to Purchase Common Stock $7.86 11/12/2020  A   750    11/12/2021 11/12/2030 Common Stock 750 (3)$0.00 750 D  

Explanation of Responses:
(1) Option becomes exercisable as to 1,250 shares on 12/31/2021 and for an additional 1,250 shares on each succeeding October 31 through 12/31/2024.
(2) In the event that the Reporting Person ceases to serve as a director of the Company, the option expires thirty days after the date upon which such service has ceased and is exercisable only to the extent exercisable on the date upon which such service ceased.
(3) Issued pursuant to the Company's 2013 Director's Stock Option Plan.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Deuser Susan M
1720 SUBLETTE AVENUE
ST. LOUIS, MO 63110
X



Signatures
Susan Deuser11/16/2020
**Signature of Reporting PersonDate

Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Allied Healthcare Products Charts.
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Allied Healthcare Products Charts.